Drug Eluting Stent Registry of Thrombosis (DESERT)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Medstar Research Institute
ClinicalTrials.gov Identifier:
NCT00812552
First received: December 18, 2008
Last updated: April 22, 2013
Last verified: April 2013
  Purpose

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Drug Eluting Stent Registry of Thrombosis

Further study details as provided by Medstar Research Institute:

Primary Outcome Measures:
  • To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis [ Time Frame: Baseline ] [ Designated as safety issue: No ]

Enrollment: 984
Study Start Date: September 2009
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Case
Late or very late drug-eluting stent thrombosis
Control
No drug-eluting stent thrombosis

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients, male or female, over 18 years of age, who are either known to have experienced late or very late drug-eluting stent thrombosis (Case), or have undergone drug-eluting stent implantation at the same facility, in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis (Control).

Criteria

Inclusion Criteria:

  • Patients over 18 years of age
  • Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis
  • Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.

Exclusion Criteria:

  • Patients not meeting the above Inclusion Criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00812552

  Hide Study Locations
Locations
United States, California
Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research
Sacramento, California, United States, 95819
United States, District of Columbia
Washington Hospital Center
Washington, District of Columbia, United States, 20010
United States, Illinois
Prairie Education and Research Cooperative
Springfield, Illinois, United States, 62701
United States, Kentucky
Lexington Cardiac Research Foundation/Central Baptist Hospital
Lexington, Kentucky, United States, 40503
United States, Maine
Maine Medical Center
Portland, Maine, United States, 04102
United States, Maryland
Washington Adventist Hospital
Takoma Park, Maryland, United States, 20912
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Lahey Clinic
Burlington, Massachusetts, United States, 01805
United States, Missouri
Saint Luke's Hospital, Mid America Heart Institute
Kansas City, Missouri, United States, 64111
United States, New Jersey
The Valley Hospital
Ridgewood, New Jersey, United States, 07450
United States, New York
New York Methodist Hospital
Brooklyn, New York, United States, 11215
Columbia University Medical Center
New York, New York, United States, 10032
United States, North Carolina
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157
United States, Ohio
Summa Health System
Akron, Ohio, United States, 44309
United States, Pennsylvania
Geisinger Health System
Danville, Pennsylvania, United States, 17822
United States, Rhode Island
The Miriam Hospital
Providence, Rhode Island, United States, 02906
United States, South Carolina
South Carolina Heart Center, PA
Columbia, South Carolina, United States, 29204
United States, Virginia
Winchester Medical Center
Winchester, Virginia, United States, 22601
Canada, Quebec
Laval Hospital
Quebec City, Quebec, Canada, G1V4G5
Switzerland
Bern University Hospital
Bern, Switzerland, 3010
Sponsors and Collaborators
Medstar Research Institute
  More Information

No publications provided

Responsible Party: Medstar Research Institute
ClinicalTrials.gov Identifier: NCT00812552     History of Changes
Other Study ID Numbers: DESERT
Study First Received: December 18, 2008
Last Updated: April 22, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Myocardial Ischemia
Thrombosis
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Embolism and Thrombosis
Heart Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 23, 2014